Cellular Biomedicine Group (CBMG) Annoucnes Dr. Xia Meng as New COO to Lead Commercialization of the Company’s CAR-T and Stem Cell Products
Tweet Send to a Friend
Cellular Biomedicine Group Inc. (NASDAQ: CBMG) today announced the appointment of Dr. Xia Meng as Chief Operating Officer for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
